Blog

Article of the day suggested by the Immune Oncology Research Institute

Photo taken from Immune Oncology Research Institute/LinkedIn

Aug 26, 2024, 21:39

Article of the day suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute made the following post on LinkedIn:

“Article of the day suggested by the Immune Oncology Research Institute.”

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

Authors: Myriam Chalabi, M.D., Ph.D., Yara L. Verschoor, M.D., Pedro Batista Tan, M.Sc., Sara Balduzzi, Ph.D., Anja U. Van Lent, M.D., Ph.D., Cecile Grootscholten, M.D., Ph.D., Simone Dokter, M.Sc., and John B. Haanen, M.D., Ph.D.

Source: Immune Oncology Research Institute/LinkedIn

Anja U. Van Lent cancer cancer care cancer immunotherapy cancer treatment cancer treatment advancements Cecile Grootscholten clinical trials Colon Cancer Research colorectal cancer Immune Oncology Research Institute immune-oncology immunotherapy research John B. Haanen Medical Research mismatch repair-deficient Myriam Chalabi neoadjuvant immunotherapy OncoDaily Oncology oncology research Oncology Updates Pedro Batista Tan PhD Research Sara Balduzzi Simone Dokter Yara L. Verschoor

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage